Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colonic Neoplasms 3Colorectal Neoplasms 2Polyps 1Fatigue 1

Interventions

Oxaliplatin 112Fluorouracil 104Leucovorin 91Irinotecan 91Capecitabine 59Bevacizumab 58Cetuximab 46Folfox protocol 28Colonoscopy 24Panitumumab 19Chemotherapy, Adjuvant 19Blood Specimen Collection 19Drug Therapy 18Nivolumab 17Magnetic Resonance Spectroscopy 17Radiotherapy 16Exercise 16Early Intervention, Educational 16Surveys and Questionnaires 15Laparoscopy 15Surgical Procedures, Operative 13Floxuridine 13Biopsy 13trifluridine tipiracil drug combination 12pembrolizumab 12XELOX 12Neoadjuvant Therapy 11Methods 11Immunohistochemistry 11Celecoxib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Colonic Neoplasms × eicosapentaenoic acid ethyl ester × Clear all
NCT03428477 2025-04-18

EMT2

University of Leeds

Phase 3 Active not recruiting
418 enrolled
Gastrointestinal

Colonic Neoplasms

NCT04682665 2024-12-04

Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

University of Leeds

Completed
81 enrolled
Gastrointestinal

Colonic Neoplasms

NCT03661047 2021-11-17

OMICC

Massachusetts General Hospital

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Polyps, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡